Available under a Creative Commons Attribution Non-Commercial Share Alike 4.0 International Licence
Phytochemicals such as methylxanthines, catechins and polyphenols show health benefits in a range of diseases although their mechanism of action is not fully understood. Primary Amine Oxidase (PrAO) is widely recognised as a therapeutic drug target for the treatment of inflammatory, vascular and neurodegenerative diseases. Previous work in our laboratories showed that caffeine inhibited bovine PrAO activity with a Ki of 1.0mM. In the present study we examined a range of methylxanthines and catechins as inhibitors of bovine PrAO. The methylxanthines tested were caffeine, paraxanthine, theophylline, theobromine and 7-methylxanthine. Of these, only theobromine was an inhibitor with an IC50 of ca. 300µM. Calculations indicated that theobromine in foods could inhibit PrAO activity by 20%. The effect of dietary catechins; epicatechin, epicatechin gallate and epigallocatechingallate was even more significant with IC50 values in the micromolar region. However, inhibition by catechins was complicated by apparent activation of PrAO at high concentrations although this was not significant at physiologically attainable levels. Nonetheless, these findings indicate that a range of dietary phytochemicals could affect PrAO activity in vivo. We suggest that the health benefits associated with consumption of certain phytochemicals may be attributed to PrAO inhibition.
Shanahan, P., O'Sullivan J., Tipton, K.F., Kinsella, G., Ryan, B.J. and Henehan, G.T. (2017). Dietary phytochemical inhibitors of primary amine oxidase. Journal of Biotechnology, 256, S96-S97, 2017. doi.org/10.1016/j.jbiotec.2017.06.1130
DIT Fiosraigh Scholar (PS)